Ameriprise Financial »

Monte Rosa Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $592k 36k 16.45
2025-12-31 $1.9M 122k 15.68
2023-03-31 $85k 11k 7.79
2022-12-31 $105k 13k 8.28
2022-09-30 $108k 13k 8.25

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
Lam Research (LRCX)
iShares S&P 500 Index (IVV)
Chevron Corporation (CVX)
Alphabet Inc Class C cs (GOOG)
Wal-Mart Stores (WMT)
Johnson & Johnson (JNJ)
Visa (V)

View all positions for Ameriprise Financial

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
Vanguard Group
Braidwell
Versant Venture Management
Vanguard Capital Management
State Street Corporation
Aisling Capital Management
Geode Capital Management
American Century Companies

View all funds holding Monte Rosa Therapeutics